JENNIFER KERSHNER: Open Payments
NPI 1689441669 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,438 in 138 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $3,944 · 2025 $3,438
Food & beverage: $3,353Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $914 |
| Janssen Biotech, Inc. | 21 | $648 |
| Ardelyx, Inc. | 13 | $348 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $340 |
| Novo Nordisk Inc | 4 | $184 |
| Lilly USA, LLC | 10 | $178 |
| Intercept Pharmaceuticals, Inc. | 8 | $144 |
| Janssen Scientific Affairs, LLC | 1 | $134 |
| Celltrion USA Inc. | 6 | $112 |
| PFIZER INC. | 6 | $103 |
Products named: TREMFYA, IBSRELA, ENTYVIO, RINVOQ, OMVOH, OCALIVA, LINZESS, MAVYRET.
Industry payments across KS — which companies pay providers there.
